
Dawn Hershman, MD, MS, medical oncologist, Columbia University Medical Center, discusses the HOPE Study, a randomized trial of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with breast cancer.

Dawn Hershman, MD, MS, medical oncologist, Columbia University Medical Center, discusses the HOPE Study, a randomized trial of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with breast cancer.

Dawn Hershman, MD, MS, medical oncologist, Columbia University Medical Center, discusses how name brands and generic brands affect drug adherence in patients with breast cancer.

Published: January 3rd 2014 | Updated:

Published: February 28th 2014 | Updated: